6.
Ding X, Wang J, Huang M, Chen Z, Liu J, Zhang Q
. Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration. Nat Commun. 2021; 12(1):2030.
PMC: 8016980.
DOI: 10.1038/s41467-021-22301-1.
View
7.
Wang Y, Zhou Y, Jiang L, Wang S, Zhu L, Zhang S
. Long-term voluntary exercise inhibited AGE/RAGE and microglial activation and reduced the loss of dendritic spines in the hippocampi of APP/PS1 transgenic mice. Exp Neurol. 2023; 363:114371.
DOI: 10.1016/j.expneurol.2023.114371.
View
8.
Morris M, Menz H, McGinley J, Watts J, Huxham F, Murphy A
. A Randomized Controlled Trial to Reduce Falls in People With Parkinson's Disease. Neurorehabil Neural Repair. 2015; 29(8):777-85.
DOI: 10.1177/1545968314565511.
View
9.
Lees A, Hardy J, Revesz T
. Parkinson's disease. Lancet. 2009; 373(9680):2055-66.
DOI: 10.1016/S0140-6736(09)60492-X.
View
10.
Michailidou I, Willems J, Kooi E, van Eden C, Gold S, Geurts J
. Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus. Ann Neurol. 2015; 77(6):1007-26.
DOI: 10.1002/ana.24398.
View
11.
Smith B, Goldberg N, Meshul C
. Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse. Brain Res. 2011; 1386:70-80.
PMC: 3073026.
DOI: 10.1016/j.brainres.2011.02.003.
View
12.
Janezic S, Threlfell S, Dodson P, Dowie M, Taylor T, Potgieter D
. Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model. Proc Natl Acad Sci U S A. 2013; 110(42):E4016-25.
PMC: 3801069.
DOI: 10.1073/pnas.1309143110.
View
13.
Marinova-Mutafchieva L, Sadeghian M, Broom L, Davis J, Medhurst A, Dexter D
. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease. J Neurochem. 2009; 110(3):966-75.
DOI: 10.1111/j.1471-4159.2009.06189.x.
View
14.
Barcia C, Ros C, Annese V, Gomez A, Ros-Bernal F, Aguado-Llera D
. IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death Dis. 2012; 3:e379.
PMC: 3434670.
DOI: 10.1038/cddis.2012.123.
View
15.
Hayes M
. Parkinson's Disease and Parkinsonism. Am J Med. 2019; 132(7):802-807.
DOI: 10.1016/j.amjmed.2019.03.001.
View
16.
Alawieh A, Langley E, Feng W, Spiotta A, Tomlinson S
. Complement-Dependent Synaptic Uptake and Cognitive Decline after Stroke and Reperfusion Therapy. J Neurosci. 2020; 40(20):4042-4058.
PMC: 7219298.
DOI: 10.1523/JNEUROSCI.2462-19.2020.
View
17.
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z
. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021; 2(3):100141.
PMC: 8454663.
DOI: 10.1016/j.xinn.2021.100141.
View
18.
Lorenzo-Garcia P, Cavero-Redondo I, Nunez de Arenas-Arroyo S, Guzman-Pavon M, Priego-Jimenez S, Alvarez-Bueno C
. Effects of physical exercise interventions on balance, postural stability and general mobility in Parkinson's disease: a network meta-analysis. J Rehabil Med. 2024; 56:jrm10329.
PMC: 10847976.
DOI: 10.2340/jrm.v56.10329.
View
19.
Cunningham C
. Microglia and neurodegeneration: the role of systemic inflammation. Glia. 2012; 61(1):71-90.
DOI: 10.1002/glia.22350.
View
20.
Wolf S, Boddeke H, Kettenmann H
. Microglia in Physiology and Disease. Annu Rev Physiol. 2016; 79:619-643.
DOI: 10.1146/annurev-physiol-022516-034406.
View